Heterozygous DNA mismatch repair gene PMS2-knockout mice are susceptible to intestinal tumor induction with N-methyl-N-nitrosourea

Carcinogenesis

Volumn 21, Issue 4, 2000, Pages 833-838

  Qin, Xiusheng ^a   Shibata, Darryl ^b   Gerson, Stanton L ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; METHYLNITROSOUREA;

ADENOCARCINOMA; ADENOMA; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASE MISPAIRING; CONTROLLED STUDY; DNA ADDUCT; DNA REPAIR; INTESTINE TUMOR; KNOCKOUT MOUSE; MICROSATELLITE INSTABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE; THYMUS LYMPHOMA;

EID: 0034007120     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.4.833     Document Type: Article

References (35)

1. Modrich, P. and Lahue, R. (1996) Mismatch repair in replication fidelity, genetic recombination and cancer biology. Annu. Rev. Biochem., 65, 101-133.
2. Lynch, H., Smyrk, T. and Watson, P. (1993) Genetics, natural history, tumor spectrum and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology, 104, 1535-1549.
3. Lynch, H.T. and Smyrk, T.C. (1996) Hereditary nonpolyposis colorectal cancer (Lynch syndrome): an updated review. Cancer, 78, 1149-1167.
4. Lu, S.L., Akiyama, Y., Nagasaki, H., Nomizu, T., Ikeda, E., Baba, S., Ushio, K., Iwama, T., Maruyama, K. and Yuasa, Y. (1996) Loss or somatic mutations of hMSH2 occur in hereditary nonpolyposis colorectal cancers with hMSH2 germline mutations. Jpn. J. Cancer Res., 87, 279-287.
5. Herman, J.G., Umar, A., Polyak, K., Graff, J.R., Ahiya, N., Issa, J.P.J., Markowitz, S., Willson, J.K.V., Hamilton, S.R., Kinzler, K.W., Kane, M.F., Kolodner, R.D., Vogelstein, B., Kunkel, T.A. and Baylin, S.B. (1998) Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl Acad. Sci. USA, 95, 6870-6875.
6. Cunningham, J.M., Christensen, E.R., Tester, D.J., Kim, C.Y., Roche, P.C., Burgart, L.J. and Thibodeau, S.N. (1998) Hypermethylation of the hMLH1 promotor in colon cancer with microsatellite instability. Cancer Res., 58, 3455-3460.
7. Hemminki, A., Peltomaki, P., Mecklin, J.P., Jarvinen, H., Salovaara, R., Nystrom-Lahti, M., de la Chapelle, A. and Aaltonen, L.A. (1994) Loss of the wild-type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer. Nature Genet., 8, 405-410.
8. Reitmair, A.H., Redstonm, M., Cai, J.C., Chuang, T.C.Y., Bjerknes, M., Cheng, H., Hay, K., Gallinger, S., Bapat, B. and Mak, T.W. (1996) Spontaneous intestinal carcinomas and skin neoplasmas in MSH2-deficient mice. Cancer Res., 56, 3842-3849.
9. Prolla, T.A., Baker, S.M., Harris, A.C., Tsao, J.L., Yao, X., Bronner, C.E., Zhang, B., Gordon, M., Reneker, J., Arnheim, N., Shibata, D., Bradley, A. and Liskay, R.M. (1998) Tumor susceptibility and spontaneous mutation in mice deficient in MLH1, PMSI and PMS2 DNA mismatch repair genes. Nature Genet., 18, 276-279.
10. Baker, S.M., Bronner, C.E., Zhang, L., Plug, A.W., Robatzek, M., Warren, G., Elliott, E.A., Yu, J., Ashley,T., Arnheim, N., Flavell, R.A. and Liskay, R.M. (1995) Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell, 82, 309-319.
11. De Wind, N., Dekker, M., Berns, A., Radman, M. and te Riele, H. (1995) Inactivation of the mouse MSH2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination and predisposition to cancer. Cell, 82, 321-330.
12. Reitmair, A.H., Schmits, R., Ewel, A., Bapat, B., Redstonm, M., Mitri, A., Waterhouse, P., Mittrucker, H.W., Wakeman, A., Liu, B., Thomason, A., Griesser, H., Gallinger, S., Ballhausen, W.G., Fishel, R. and Mak, T.W. (1995) MSH2 deficient mice are viable and susceptible to lymphoid tumors. Nature Genet., 11, 64-70.
13. Edelmann, W., Yang, K., Kuraguchi, M., Heyer, J., Lia, M., Kneitz, B., Fan, K., Brown, A.M.C., Lipkin, M. and Kucherlapati, R. (1999) Tumorigenesis in Mlh1 and Mlh1/Apc1638N mutant mice. Cancer Res., 59, 1301-1307.
14. Reitmair, A.H., Cai, J.C., Matthew, B., Redstonm, M., Cheng, H., Pind, M.T.L., Hay, K., Mitri, A., Bapat, B.V., Mak, T.W. and Gallinger, S. (1996) MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis. Cancer Res., 56, 2922-2926.
15. -/-; Min mice. Cancer Res., 58, 1087-1089.
16. De Wind, N., Dekker, M., Van Rossum, A., Van der Valk, M. and te Riele, H. (1998) Mouse models for hereditary nonpolyposis colorectal cancer. Cancer Res., 58, 248-255.
17. Tsao, J.L., Davis, S.D., Baker, S.M., Liskay, R.M. and Shibata, D. (1997) Intestinal stem cell division and genetic diversity. A computer and experimental analysis. Am. J. Pathol., 151, 573-579.
18. Young, J., Leggett, B., Gustafson, C., Ward, M., Searle, J., Thomas, L., Buttenshaw, R. and Chenevix-Trench, G. (1993) Genomic instability occurs in colorectal carcinomas but not in adenomas. Hum. Mutat., 2, 351-354.
19. Jacoby, R.F., Marshall, D.J., Kailas, S., Schlack, S., Harms, B. and Love, R. (1995) Genetic instability associated with adenoma to carcinoma progression in hereditary nonpolyposis colon cancer. Gastroenterology, 109, 73-82.
20. Parsons, R., Li, G.-M., Longley, M., Modrich, P., Liu, B., Berkk, T., Hamilton, S.R., Kinzler, K.W. and Vogelstein, B. (1995) Mismatch repair deficiency in phenotypically normal human cells. Science, 268, 738-740.
21. Luongo, C., Moser, A.R., Gledhill, S. and Dove, W.F. (1994) Loss of APC + in intestinal adenomas from Min mice. Cancer Res., 54, 5947-5952.
22. Levy, D.B., Smith, K.J., Beazer-Barclay, Y., Hamilton, S.R., Vogelstein, B. and Kinzler, K.W. (1994) Inactivation of both APC allele in human and mouse tumors. Cancer Res., 54, 5953-5958.
23. Powell, S.M., Zilz, N., Beazer-Barclay, Y. Bryan, T.M., Hamilton, S.R., Thibodeau, S.N., Vogelstein, B. and Kinzler, K.W. (1992) APC mutations occur early during colorectal tumorigenesis. Nature, 359, 235-237.
24. Young, J., Leggett, B., Gustafson, C., Ward, M., Searle J., Thomas, L., Buttenshaw, R. and Chenevix-Trench, G. (1993) Genomic instability occurs in colorectal carcinomas but not in adenomas. Hum. Mutat., 2, 351-354.
25. Qin, X., Liu, L. and Gerson, S.L. (1999) Mice defective in the DNA mismatch gene PMS2 are hypersensitive to MNU induced thymic lymphoma and are partially protected by transgenic expression of human MGMT. Oncogene, 18, 4394-4400.
26. Qin, X., Zhou, H., Liu, L. and Gerson, S.L. (1999) Transgenic expression of human MGMT blocks the hypersensitivity of PMS2-deficient mice to low dose MNU thymic lymphomagenesis. Carcinogenesis, 20, 1667-1673.
27. Qin, X., Zhou, H., Liu, L. and Gerson, S.L. (1999) PMS2-deficient mice are hypersensitive to GI tumor induction by azoxymethane and protected by MGMT overexpression. Proc. Am. Assoc. Cancer Res., 40, 57.
28. Qin, X., Nakatsuru, Y., Kohyama, K. and Ishikawa, T. (1990) DNA adduct formation and unscheduled DNA synthesis in rat esophagus in vivo after treatment with N-methyl-N-nitrosourea. Carcinogenesis, 11, 235-238.
29. Qin, X., Zarkovic, M., Nakatsuru, Y. Arai, M., Oda, H. and Ishikawa, T. (1994) DNA adduct formation and assessment of aberrant crypt foci in vivo in the rat colon mucosa after treatment with N-methyl-N-nitrosourea. Carcinogenesis, 15, 851-855.
30. 6-methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea. Oncogene, 18, 3783-3787.
31. 6-methylguanine. Nature, 308, 201-203.
32. 6-alkylguanine-DNA alkyltransferase. Proc. Natl Acad. Sci. USA, 86, 8620-8624.
33. Liu, L., Markowitz, S. and Gerson, S.L. (1996) Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. Cancer Res., 56, 5375-5379.
34. Fink, D., Aebi, S. and Howell, S.B. (1998) The role of DNA mismatch repair in drug resistance. Clin. Cancer Res., 4, 1-6.
35. Andrew, S.E., McKinnon, M., Cheng, B.S., Francis, A., Penney, J., Reitmair, A.H., Mak, T.W. and Jirik, F.R. (1998) Tissues of MSH2-deficient mice demonstrate hypermutability on exposure to a DNA methylating agent. Proc. Natl Acad. Sci. USA, 95, 1126-1130.